Skip to main content
. Author manuscript; available in PMC: 2012 Apr 24.
Published in final edited form as: AIDS. 2011 Apr 24;25(7):957–966. doi: 10.1097/QAD.0b013e32834541d9
Sponsors: US National Institutes of Health (R Black, L Soto-Torres, S Estep)
Endo Pharmaceuticals Solutions Inc (A Profy)
ReProtect (T Moench)
Protocol Chair: Salim S Abdool Karim
Blantyre, Malawi: T Taha, N Kumwenda, B Makanani, S Hurst, C Nkhoma, E Kachale Durban and Hlabisa,
South Africa: G Ramjee, R Govinden, N Coumi, N Dladla-Qwabe, S Ganesh, N Morar
Harare, Zimbabwe: ZM Chirenje, N Padian, A van der Straten, T Magure, M Mlingo, N Mgodi
Lilongwe, Malawi: I Hoffman, F Martinson, T Tembo, L Chinula, T Mvalo
Lusaka, Zambia: G Parham, M Kapina, C Reid, M Kasaro, A Brahmi
Philadelphia, USA: L Maslankowski, J Prince, N Tustin, S Whittington, E Yu
Coordinating Center: W Cates, A Coletti, K Gomez, R White
Statistical Center: M Cianciola, C Kelly, C Miller, B Mâsse, B Richardson, T Fleming
Network Laboratory: S Hillier, E Piwowar-Manning, L Rabe